Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA1091931
Max Phase: Preclinical
Molecular Formula: C19H18BrN5O4
Molecular Weight: 460.29
Molecule Type: Small molecule
Associated Items:
ID: ALA1091931
Max Phase: Preclinical
Molecular Formula: C19H18BrN5O4
Molecular Weight: 460.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=c1[nH]c(=O)n([C@H]2C[C@H](n3cc(-c4ccccc4)nn3)[C@@H](CO)O2)cc1/C=C/Br
Standard InChI: InChI=1S/C19H18BrN5O4/c20-7-6-13-9-24(19(28)21-18(13)27)17-8-15(16(11-26)29-17)25-10-14(22-23-25)12-4-2-1-3-5-12/h1-7,9-10,15-17,26H,8,11H2,(H,21,27,28)/b7-6+/t15-,16+,17+/m0/s1
Standard InChI Key: DMKMKCDASKTBRN-GBTQTLIESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 460.29 | Molecular Weight (Monoisotopic): 459.0542 | AlogP: 1.68 | #Rotatable Bonds: 5 |
Polar Surface Area: 115.03 | Molecular Species: NEUTRAL | HBA: 8 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 9 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.74 | CX Basic pKa: | CX LogP: 2.08 | CX LogD: 2.07 |
Aromatic Rings: 3 | Heavy Atoms: 29 | QED Weighted: 0.60 | Np Likeness Score: -0.18 |
1. Van Poecke S, Negri A, Gago F, Van Daele I, Solaroli N, Karlsson A, Balzarini J, Van Calenbergh S.. (2010) 3'-[4-Aryl-(1,2,3-triazol-1-yl)]-3'-deoxythymidine analogues as potent and selective inhibitors of human mitochondrial thymidine kinase., 53 (7): [PMID:20218622] [10.1021/jm901532h] |
Source(1):